Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2001 Dec;60(12):1088–1094. doi: 10.1136/ard.60.12.1088

Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis

M Smieja 1, D MacPherson 1, W Kean 1, M Schmuck 1, C Goldsmith 1, W Buchanan 1, L Hart 1, J Mahony 1
PMCID: PMC1753446  PMID: 11709448

Abstract

OBJECTIVE—To determine whether long term doxycycline improves symptoms in patients with chronic seronegative or reactive arthritis.
METHODS—A randomised, triple blind, controlled clinical trial of three months' treatment with doxycycline or placebo of patients with chronic reactive or seronegative arthritis was conducted. The primary study end points were three month pain and functional status measured by a self administered Arthritis Impact Measurement Scales version 2 (AIMS2) quality of life questionnaire. Secondary end points were pain and functional status at 6-12 months, three month rheumatologist assessed joint count, pain, and arthritis activity, and treatment efficacy in those with previous exposure to chlamydia.
RESULTS—Of 60 patients randomly allocated to receive doxycycline or placebo, results from 37 were evaluable at three months. Groups were well balanced for major prognostic variables. Doxycycline had no detectable effect at three months on pain change scores (mean difference 1.5, 95% CI −1.2 to 4.2, p=0.25) or composite functional change scores (mean difference 0.8, 95% CI −5.6 to 7.1, p=0.81). Furthermore, there were no differences in secondary study end points, and no apparent treatment effect in patients with previous chlamydia infection.
CONCLUSION—Three months' treatment with doxycycline did not improve pain or functional status in patients with chronic reactive or seronegative arthritis.



Full Text

The Full Text of this article is available as a PDF (143.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. J., Firschein H. E., Meenan R. F. Sensitivity of a health status measure to short-term clinical changes in arthritis. Arthritis Rheum. 1989 Jul;32(7):844–850. [PubMed] [Google Scholar]
  2. Bardin T., Enel C., Cornelis F., Salski C., Jorgensen C., Ward R., Lathrop G. M. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum. 1992 Feb;35(2):190–194. doi: 10.1002/art.1780350210. [DOI] [PubMed] [Google Scholar]
  3. Braun J., Laitko S., Treharne J., Eggens U., Wu P., Distler A., Sieper J. Chlamydia pneumoniae--a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis. 1994 Feb;53(2):100–105. doi: 10.1136/ard.53.2.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Braun J., Tuszewski M., Eggens U., Mertz A., Schauer-Petrowskaja C., Döring E., Laitko S., Distler A., Sieper J., Ehlers S. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides. J Rheumatol. 1997 Jun;24(6):1092–1100. [PubMed] [Google Scholar]
  5. CSONKA G. W. Recurrent attacks in Reiter's disease. Arthritis Rheum. 1960 Apr;3:164–169. doi: 10.1002/art.1780030208. [DOI] [PubMed] [Google Scholar]
  6. CSONKA G. W. The course of Reiter's syndrome. Br Med J. 1958 May 10;1(5079):1088–1090. doi: 10.1136/bmj.1.5079.1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Deighton C. Beta haemolytic streptococci and reactive arthritis in adults. Ann Rheum Dis. 1993 Jun;52(6):475–482. doi: 10.1136/ard.52.6.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Frydén A., Bengtsson A., Foberg U., Svenungsson B., Castor B., Kärnell A., Schvarcz R., Lindblom B., Kihlström E. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. BMJ. 1990 Dec 8;301(6764):1299–1302. doi: 10.1136/bmj.301.6764.1299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gérard H. C., Branigan P. J., Schumacher H. R., Jr, Hudson A. P. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol. 1998 Apr;25(4):734–742. [PubMed] [Google Scholar]
  10. Hughes R., Keat A. Reactive arthritis: the role of bacterial antigens in inflammatory arthritis. Baillieres Clin Rheumatol. 1992 Jun;6(2):285–308. doi: 10.1016/s0950-3579(05)80175-x. [DOI] [PubMed] [Google Scholar]
  11. Inman R. D., Whittum-Hudson J. A., Schumacher H. R., Hudson A. P. Chlamydia and associated arthritis. Curr Opin Rheumatol. 2000 Jul;12(4):254–262. doi: 10.1097/00002281-200007000-00004. [DOI] [PubMed] [Google Scholar]
  12. Keat A. C., Thomas B. J., Taylor-Robinson D., Pegrum G. D., Maini R. N., Scott J. T. Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis. 1980 Oct;39(5):431–437. doi: 10.1136/ard.39.5.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med. 1983 Dec 29;309(26):1606–1615. doi: 10.1056/NEJM198312293092604. [DOI] [PubMed] [Google Scholar]
  14. Lauhio A., Leirisalo-Repo M., Lähdevirta J., Saikku P., Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum. 1991 Jan;34(1):6–14. doi: 10.1002/art.1780340103. [DOI] [PubMed] [Google Scholar]
  15. Meenan R. F., Gertman P. M., Mason J. H., Dunaif R. The arthritis impact measurement scales. Further investigations of a health status measure. Arthritis Rheum. 1982 Sep;25(9):1048–1053. doi: 10.1002/art.1780250903. [DOI] [PubMed] [Google Scholar]
  16. Meenan R. F., Gertman P. M., Mason J. H. Measuring health status in arthritis. The arthritis impact measurement scales. Arthritis Rheum. 1980 Feb;23(2):146–152. doi: 10.1002/art.1780230203. [DOI] [PubMed] [Google Scholar]
  17. Meenan R. F., Mason J. H., Anderson J. J., Guccione A. A., Kazis L. E. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum. 1992 Jan;35(1):1–10. doi: 10.1002/art.1780350102. [DOI] [PubMed] [Google Scholar]
  18. Nanagara R., Li F., Beutler A., Hudson A., Schumacher H. R., Jr Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum. 1995 Oct;38(10):1410–1417. doi: 10.1002/art.1780381008. [DOI] [PubMed] [Google Scholar]
  19. Panayi G. S., Clark B. Minocycline in the treatment of patients with Reiter's syndrome. Clin Exp Rheumatol. 1989 Jan-Feb;7(1):100–101. [PubMed] [Google Scholar]
  20. Rahman M. U., Hudson A. P., Schumacher H. R., Jr Chlamydia and Reiter's syndrome (reactive arthritis). Rheum Dis Clin North Am. 1992 Feb;18(1):67–79. [PubMed] [Google Scholar]
  21. Rich E., Hook E. W., 3rd, Alarcón G. S., Moreland L. W. Reactive arthritis in patients attending an urban sexually transmitted diseases clinic. Arthritis Rheum. 1996 Jul;39(7):1172–1177. doi: 10.1002/art.1780390715. [DOI] [PubMed] [Google Scholar]
  22. Schumacher H. R., Jr, Magge S., Cherian P. V., Sleckman J., Rothfuss S., Clayburne G., Sieck M. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Immunocytochemical identification of chlamydial antigen in patients with early disease. Arthritis Rheum. 1988 Aug;31(8):937–946. doi: 10.1002/art.1780310801. [DOI] [PubMed] [Google Scholar]
  23. Sieper J., Braun J., Brandt J., Miksits K., Heesemann J., Laitko S., Sörensen H., Distler A., Kingsley G. Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis. J Rheumatol. 1992 Aug;19(8):1236–1242. [PubMed] [Google Scholar]
  24. Sieper J., Braun J., Kingsley G. H. Report on the Fourth International Workshop on Reactive Arthritis. Arthritis Rheum. 2000 Apr;43(4):720–734. doi: 10.1002/1529-0131(200004)43:4<720::AID-ANR2>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  25. Sieper J., Fendler C., Laitko S., Sörensen H., Gripenberg-Lerche C., Hiepe F., Alten R., Keitel W., Groh A., Uksila J. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum. 1999 Jul;42(7):1386–1396. doi: 10.1002/1529-0131(199907)42:7<1386::AID-ANR12>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  26. Taylor-Robinson D., Gilroy C. B., Thomas B. J., Keat A. C. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet. 1992 Jul 11;340(8811):81–82. doi: 10.1016/0140-6736(92)90399-n. [DOI] [PubMed] [Google Scholar]
  27. Thomson G. T., DeRubeis D. A., Hodge M. A., Rajanayagam C., Inman R. D. Post-Salmonella reactive arthritis: late clinical sequelae in a point source cohort. Am J Med. 1995 Jan;98(1):13–21. doi: 10.1016/S0002-9343(99)80076-X. [DOI] [PubMed] [Google Scholar]
  28. Wakefield D., McCluskey P., Verma M., Aziz K., Gatus B., Carr G. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum. 1999 Sep;42(9):1894–1897. doi: 10.1002/1529-0131(199909)42:9<1894::AID-ANR14>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  29. Weyand C. M., Goronzy J. J. Clinically silent infections in patients with oligoarthritis: results of a prospective study. Ann Rheum Dis. 1992 Feb;51(2):253–258. doi: 10.1136/ard.51.2.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Whaley K., Downie W. W., Dick W. C., Nuki G., Schofield C. B., Anderson J. Clinical trial of lincomycin hydrochloride in Reiter's disease. Br Med J. 1969 May 17;2(5654):421–422. doi: 10.1136/bmj.2.5654.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wilkinson N. Z., Kingsley G. H., Jones H. W., Sieper J., Braun J., Ward M. E. The detection of DNA from a range of bacterial species in the joints of patients with a variety of arthritides using a nested, broad-range polymerase chain reaction. Rheumatology (Oxford) 1999 Mar;38(3):260–266. doi: 10.1093/rheumatology/38.3.260. [DOI] [PubMed] [Google Scholar]
  32. Yli-Kerttula T., Luukkainen R., Yli-Kerttula U., Möttönen T., Hakola M., Korpela M., Sanila M., Parviainen J., Uksila J., Vainionpä R. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis. 2000 Jul;59(7):565–570. doi: 10.1136/ard.59.7.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zhang Y., Gripenberg-Lerche C., Söderström K. O., Toivanen A., Toivanen P. Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model. Arthritis Rheum. 1996 Jul;39(7):1238–1243. doi: 10.1002/art.1780390725. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES